Alector
Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.
Check the tech stack behind alector.com. Find a founder email at alector.com.
About
Alector is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases such as Alzheimer's, Parkinson's, and frontotemporal dementia. They leverage insights from human genetics, neuroscience, and immunology to create treatments that aim to remove toxic proteins, replace deficient proteins, and restore immune and nerve cell function. The company also develops a proprietary Alector Brain Carrier (ABC) platform to improve drug delivery across the blood-brain barrier. Teams look it up for Biotech, MedTech, HealthTech.
Frequently asked
What does Alector do?
Alector is a Biotech company that offers Platform. Teams look it up for MedTech, HealthTech, Drug Discovery. It is based in South San Francisco, United States and was founded in 2013. Public records show about 151 people and $163M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Alector raised?
Alector has raised a total of $163M in funding. The most recent round on record is Series E.
Where is Alector headquartered?
Alector is headquartered in South San Francisco, United States.
When was Alector founded?
Alector was founded in 2013.
What industry does Alector operate in?
Alector operates in Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials.
How many employees does Alector have?
Alector has approximately 151 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.